Niquitin Mint (Nicotine Resinate)

Nicotine resinate, the active ingredient in Niquitin Mint, is a nicotine presented as an oral formulation for oral use. It belongs to the nicotine drug class and is indicated for smoking cessation, helping adult smokers who wish to quit by reducing withdrawal symptoms. The product is marketed in the European Union and is available over the counter without a prescription. It is designed to be taken as directed by a healthcare professional, typically in a step‑down regimen to gradually lower nicotine dependence.

GNH USA supplies Niquitin Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niquitin Mint, containing nicotine resinate, is used within the smoking cessation therapeutic area to aid adults who want to quit tobacco use. - Smoking cessation: Reduces nicotine withdrawal symptoms and cravings, facilitating a gradual reduction in tobacco use. - Adjunct to counseling: Improves quit rates when combined with behavioral support programs.

Common Side Effects: - Nausea: Mild stomach upset that usually resolves with continued use. - Mouth irritation: Tingling or soreness in the oral cavity. - Dizziness: Transient light‑headedness, especially on initial dosing. - Insomnia: Difficulty falling or staying asleep. - Headache: Tension‑type headache that may lessen over time. - Hiccups: Involuntary diaphragm contractions. Serious or Rare Side Effects: - Severe allergic reaction: Rash, swelling, or difficulty breathing requiring immediate medical attention. - Chest pain: Possible indication of cardiovascular strain. - Arrhythmia: Irregular heart rhythm that should be evaluated promptly.

Before using Niquitin Mint, consider the following precautions: - Cardiovascular assessment: Evaluate heart disease risk before initiating therapy. - Medical supervision: Use under guidance of a healthcare professional, especially for first‑time users. - Non‑smoker avoidance: Not intended for individuals who do not currently smoke. - Pregnancy and lactation: Discuss risks with a physician; use only if benefits outweigh potential risks. - Dependence monitoring: Watch for signs of continued nicotine dependence. - Store at ambient temperature: Keep below 25°C in the original packaging, protect from moisture.

Nicotine resinate may interact with several drug classes. Major Interactions (Avoid): - Beta‑blockers: Nicotine can blunt their antihypertensive effect. - Insulin: May alter glucose control, requiring dose adjustments. - CYP2A6 inhibitors: Can increase nicotine plasma concentrations. Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine): May increase nausea when combined. - Antihypertensives: Blood pressure response may be variable. - Theophylline: Nicotine can raise its serum levels, necessitating monitoring.